Cambridge Biotech Targets Artificial Pancreas Market With Fast Insulin and Stable Glucagon
UK biotech Arecor has raised €6.7M to help fund development of its extra-fast insulin and…
10/09/2018 - 2 minutes
Diabetes
Update: Non-Invasive Glucose Monitoring Device Moves Forward With Series B Funding
Update (10/09/2018): RSP Systems has raised an additional €3.85M that raises the total amount of…
10/09/2018 - 2 minutes
Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics
In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1…
06/09/2018 - 2 minutes
Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M
Novo Nordisk acquired the UK biotech Ziylo, which develops glucose-responsive insulin treatments for diabetes that…
17/08/2018 - 2 minutes
Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other…
16/05/2018 - 2 minutes
French Double-Hormone Diabetes Treatment to be Tested in Humans for the First Time
Adocia, a French biotech, will initiate a Phase I clinical study to test a diabetes…
16/04/2018 - 2 minutes
Graphene Skin Patch Measures Blood Sugar Without a Needle
Researchers in the UK have developed a skin patch that measures blood sugar levels without the…
12/04/2018 - 2 minutes
Cheese-Producing Bacteria Could Help Reverse Type 1 Diabetes
ActoBio Therapeutics has received permission from the FDA to start a clinical trial for a…
03/04/2018 - 2 minutes
This Swedish Discovery Could Change the Way We Treat Diabetes
Swedish researchers have found that insulin-producing cells alone are not enough to fine-tune blood sugar…
15/03/2018 - 3 minutes
French Biotech Takes its Oral Diabetes Drug to Phase III
Update (13/03/2018): Poxel has started two more Phase III trials in Japan testing its drug…
13/03/2018 - 3 minutes
French Biotech Targets Gut Microbiome to Treat Diabetes
Valbiotis has shown that its treatment restores diversity in a population of gut microorganisms imbalanced…
08/03/2018 - 3 minutes
Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
23/02/2018 - 3 minutes
